Cargando…

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

BACKGROUND: Prostate cancer (PCa) accounts for 20% of all cancers in subjects over 50 years in Italy. The majority of patients with PCa present with localized disease at the time of diagnosis, but many patients develop recurrent metastatic disease after treatment with curative intent. Androgen depri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Restelli, Umberto, Ceresoli, Giovanni Luca, Croce, Davide, Evangelista, Laura, Maffioli, Lorenzo Stefano, Gianoncelli, Letizia, Bombardieri, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724712/ https://www.ncbi.nlm.nih.gov/pubmed/29263702 http://dx.doi.org/10.2147/CMAR.S148323

Ejemplares similares

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]
Publicado: (2018)

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives
por: Croce, Davide, et al.
Publicado: (2016)

The economic burden of obesity in Italy: a cost-of-illness study
por: d’Errico, Margherita, et al.
Publicado: (2021)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
por: Restelli, Umberto, et al.
Publicado: (2015)

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
por: Restelli, Umberto, et al.
Publicado: (2017)

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
por: Restelli, Umberto, et al.
Publicado: (2017)

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
por: Restelli, Umberto, et al.
Publicado: (2017)

Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR
por: Restelli, Umberto, et al.
Publicado: (2020)

The Economic Burden of Metastatic Castration Resistant Prostate Cancer and Skeletal Related Events in Japanese University Hospitals
por: Satoh, Takefumi, et al.
Publicado: (2018)

Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2013)

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2014)

The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study
por: Fattore, Giovanni, et al.
Publicado: (2012)

Cost of illness and economic burden of chronic lymphocytic leukemia
por: Blankart, Carl Rudolf, et al.
Publicado: (2013)

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review
por: Silvola, Sofia, et al.
Publicado: (2023)

Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2012)

Economic burden of pneumococcal disease in children in Liguria, Italy
por: Amicizia, Daniela, et al.
Publicado: (2022)

Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
por: Peters, Michel L., et al.
Publicado: (2017)

Cost of illness of urothelial bladder cancer in Italy
por: Gerace, Claudio, et al.
Publicado: (2017)

Economic burden of illness of acute coronary syndromes: medical and productivity costs
por: Zhao, Zhenxiang, et al.
Publicado: (2011)

The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study
por: AKBARI SARI, Ali, et al.
Publicado: (2015)

The economic burden of stroke: a systematic review of cost of illness studies
por: Strilciuc, Stefan, et al.
Publicado: (2021)

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
por: Restelli, Umberto, et al.
Publicado: (2017)

Burden of Crohn’s disease: economics and quality of life aspects in Italy
por: Benedini, Viviano, et al.
Publicado: (2012)

Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2013)

The short-term economic burden of gestational diabetes mellitus in Italy
por: Meregaglia, Michela, et al.
Publicado: (2018)

Economic and Disease Burden of Dengue Illness in India
por: Shepard, Donald S., et al.
Publicado: (2014)

Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
por: Peters, Michel L., et al.
Publicado: (2018)

Prognostic and predictive role of [(18)F]fluorodeoxyglucose positron emission tomography (FDG‐PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up‐front pemetrexed‐based chemotherapy
por: Zucali, Paolo Andrea, et al.
Publicado: (2017)

The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases
por: Cortaredona, Sébastien, et al.
Publicado: (2017)

Economic burden of maternal morbidity – A systematic review of cost-of-illness studies
por: Moran, Patrick S., et al.
Publicado: (2020)

Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
por: Ignatova, Valentina, et al.
Publicado: (2022)

Economic burden of type 2 diabetes in Iran: A cost‐of‐illness study
por: Jalilian, Habib, et al.
Publicado: (2023)

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
por: Cox, Ingrid A., et al.
Publicado: (2022)

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis
por: Monzani, Roberta, et al.
Publicado: (2020)

Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis
por: Restelli, Umberto, et al.
Publicado: (2019)

Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
por: Mosillo, Claudia, et al.
Publicado: (2022)

Assessing the Economic Burden of Disease in Migrants: The Diabetes Case in Northern Italy
por: Ferrara, Pietro
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k83gkeabguhvav1c0ajukrrsdm